Lovastatin induces the formation of abnormal myelin‐like membrane sheets in primary oligodendrocytes
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Statins, well‐known inhibitors of cholesterol synthesis and protein isoprenylation, have been proposed as therapeutic drugs for multiple sclerosis (MS). As lovastatin and simvastatin, which are currently tested for their use in MS, can cross the blood‐brain barrier, they may affect cellular processes in the central nervous system. This is especially relevant with respect to remyelination as a proposed additional treatment for MS, because cholesterol is a major component of myelin. Here, we show that primary oligodendrocytes, treated with lovastatin, form extensive membrane sheets, which contain galactosphingolipids. However, these membrane sheets are devoid of the major myelin proteins, myelin basic protein (MBP) and proteolipid protein (PLP). Reduced MBP protein expression was confirmed by SDS‐PAGE and Western blotting, and in situ hybridization experiments revealed that lovastatin blocks MBP mRNA transport into oligodendrocyte processes. In contrast, PLP expression was only mildly affected by lovastatin. However, lovastatin treatment resulted in intracellular accumulation of PLP and prevented its translocation to the cell surface. Interestingly, another inhibitor of cholesterol synthesis (ro48‐8071), which does not interfere with isoprenylation, had a similar effect on the localization of PLP, but it did not affect MBP expression and localization. These results suggest that lovastatin affects PLP transport predominantly by the inhibition of cholesterol synthesis, whereas reduced MBP expression is caused by impaired isoprenylation. Based on these results we recommend to carefully monitor the effect of statins on myelination prior to their use in demyelinating diseases. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Brain Cholesterol: Long Secret Life Behind a Barrier
Björkhem, I., & Meaney, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000120374.59826.1b · Cited by 1,044 · cited 1×
“Although the cholesterol turnover in the adult brain is low (Bjorkhem and Meaney, 2004), statin treatment can result in an altered cholesterol metabolism in the CNS (Locatelli et al., 2002).”
BackgroundHigh cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799
Rab6 regulates transport and targeting of exocytotic carriers
Grigoriev, I., Splinter, D., Keijzer, N., Wulf, P. S., Demmers, J., Ohtsuka, T., Modesti, M., Maly, I. V., Grosveld, F., Hoogenraad, C. C., et al. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.06.010 · Cited by 361
Simons, M., Krämer, E.-M., Thiele, C., Stoffel, W., & Trotter, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.1.143 · Cited by 293
Membrane Association and Targeting of Prenylated Ras-like GTPases
Seabra, M. C. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00120-4 · Cited by 261
Liang, X., Draghi, N. A., & Resh, M. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5319-03.2004 · Cited by 255
Ghittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Baldari, C. T. (2005) · The FASEB Journal · doi:10.1096/fj.04-2702fje · Cited by 154 · cited 2×
“cyte activation and the stabilization of the blood-brain barrier (Ghittoni et al., 2005; Ifergan et al., 2006).”
BackgroundStatins induce differentiation and cell death in neurons and astroglia
März, P., Otten, U., & Miserez, A. R. (2007) · Glia · doi:10.1002/glia.20422 · Cited by 75 · cited 1×
“In addition, the presence of astrocytes may reduce the toxicity of lovastatin, because such a beneficial effect of astrocytes has been described for neurons (M€arz et al., 2007).”
Background
Cited by
Cholesterol: its regulation and role in central nervous system disorders
Orth, M., & Bellosta, S. (2012) · Cholesterol · doi:10.1155/2012/292598 · Cited by 339
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
Chrast, R., Saher, G., Nave, K.-A., & Verheijen, M. H. G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009761 · Cited by 314
Voskuhl, R. R., Itoh, N., Tassoni, A., Matsukawa, M. A., Ren, E., Tse, V., Jang, E., Suen, T. T., & Itoh, Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821306116 · Cited by 162
On the biogenesis of myelin membranes: Sorting, trafficking and cell polarity
Baron, W., & Hoekstra, D. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.10.085 · Cited by 162
Self-citationStatin Therapy Inhibits Remyelination in the Central Nervous System
Miron, V. E., Zehntner, S. P., Kuhlmann, T., Ludwin, S. K., Owens, T., Kennedy, T. E., Bedell, B. J., & Antel, J. P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080947 · Cited by 141
Metadata
- Authors
- Maier, O., De Jonge, J., Nomden, A., Hoekstra, D., & Baron, W.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2008-09-23
- Volume
- 57
- Issue
- 4
- Pages
- 402-413
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2025953332
- Cited by
- 43
- References
- 9
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lovastatin induces the formation of abnormal myelin‐like membrane sheets in primary oligodendrocytes. https://app.cochat.ai/papers/10.1002/glia.20769
- The paper
- Maier, O., De Jonge, J., Nomden, A., Hoekstra, D., & Baron, W. (2009). Lovastatin induces the formation of abnormal myelin‐like membrane sheets in primary oligodendrocytes. Glia. https://doi.org/10.1002/glia.20769
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.